913721-70-7Relevant articles and documents
PHARMACEUTICAL COMBINATION OF A SPECIFIC THIENOPYRIDONE DERIVATIVE WITH AN FXR AGONIST FOR THE TREATMENT OF LIVER DISEASES
-
Page/Page column 14; 15, (2021/03/05)
The invention relates to a pharmaceutical combination comprising a specific thienopyridone derivative, namely 2-chloro-4-hydroxy-3-(5-hydroxytetralin-6-yl)-5-phenyl-7H-thieno[2,3-b]pyridin-6-one or one of its pharmaceutically acceptable salts and/or solva
PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASES
-
Page/Page column 15, (2021/10/15)
The invention relates to a pharmaceutical combination comprising a specific thienopyridone derivative, namely 2-chloro-4-hydroxy-3-(5-hydroxytetralin-6-yl)-5-phenyl-7H-thieno[2,3- b]pyridin-6-one or one of its pharmaceutically acceptable salts and/or solv
USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF ADRENOLEUKODYSTROPHY OR ADRENOMYELONEUROPATHY
-
Page/Page column 18-19, (2021/10/02)
The invention relates to the use of a thienopyridone derivative, or a pharmaceutical composition comprising the same, in the treatment of genetic neurodegenerative diseases selected from adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).